Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Description

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Conditions

cGVHD

Study Overview

Study Details

Study overview

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Condition
cGVHD
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama Birmingham, Birmingham, Alabama, United States, 35294

Phoenix

Mayo Clinic Arizona, Phoenix, Arizona, United States, 85054

Duarte

City of Hope, Duarte, California, United States, 91010

Los Angeles

USC Norris Comprehensive Cancer Center, Los Angeles, California, United States, 90033

Aurora

University of Colorado, Aurora, Colorado, United States, 80309

Jacksonville

Mayo Clinic Jacksonville, Jacksonville, Florida, United States, 32224

Orlando

AdventHealth Orlando, Orlando, Florida, United States, 32803

Atlanta

Emory University, Atlanta, Georgia, United States, 30322

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

Chicago

Rush University Medical Group, Chicago, Illinois, United States, 60612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 18 years inclusive at the time of signing the ICF
  • * Allogeneic SCT 90 to 180 days prior to enrollment
  • * Able to comprehend and willing to provide informed consent
  • * Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel
  • * There are no exclusion criteria for this study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Incyte Corporation,

Study Record Dates

2027-10-15